Your browser doesn't support javascript.
loading
Methionine and Kynurenine Activate Oncogenic Kinases in Glioblastoma, and Methionine Deprivation Compromises Proliferation.
Palanichamy, Kamalakannan; Thirumoorthy, Krishnan; Kanji, Suman; Gordon, Nicolaus; Singh, Rajbir; Jacob, John R; Sebastian, Nikhil; Litzenberg, Kevin T; Patel, Disha; Bassett, Emily; Ramasubramanian, Brinda; Lautenschlaeger, Tim; Fischer, Steven M; Ray-Chaudhury, Abhik; Chakravarti, Arnab.
Afiliación
  • Palanichamy K; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio. Kamalakannan.palanichamy@osumc.edu.
  • Thirumoorthy K; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio. Environmental Analytical Chemistry Division, School of Advanced Sciences, VIT University, Vellore, India.
  • Kanji S; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Gordon N; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Singh R; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Jacob JR; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Sebastian N; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Litzenberg KT; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Patel D; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Bassett E; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Ramasubramanian B; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Lautenschlaeger T; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
  • Fischer SM; Segment Marketing/Life Science Research, Agilent Technologies, Santa Clara, California.
  • Ray-Chaudhury A; Neuropathology Unit, Surgical Neurology Branch/NINDS, NIH, Bethesda, Maryland.
  • Chakravarti A; Department of Radiation Oncology, James Cancer Hospital and Solove Research Institute, The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, Ohio.
Clin Cancer Res ; 22(14): 3513-23, 2016 07 15.
Article en En | MEDLINE | ID: mdl-26936918

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oncogenes / Glioblastoma / Proliferación Celular / Quinurenina / Metionina Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oncogenes / Glioblastoma / Proliferación Celular / Quinurenina / Metionina Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article